Biosynex Pharma Benelux

Sint-Joost-ten-Node ·KBO/BCE: BE 0787.324.947

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	01-07-2025	30 d early	2025-00217500
31-12-2023	31-07-2024	17-07-2024	14 d early	2024-00259347
31-12-2022	31-07-2023	30-08-2023	30 d late	2023-00403502

Metric	This company	Sector median	Position in the sector
Solvency	69.3%	39.7%	better than 75% of 976 sector peers
Net result	€-715k	€32k	better than 5% of 976 sector peers
Equity	€2.38M	€152k	better than 82% of 977 sector peers
Gross operating margin	€212k	€59k	better than 81% of 817 sector peers
Staff costs	€524k	€194k	higher than 72% of 258 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€3.43M
Fixed assets	21/28	€2.42M
Intangible fixed assets	21	€2.39M
Tangible fixed assets	22/27	€29k
Financial fixed assets	28	€2k
Current assets	29/58	€1.01M
Stocks & contracts in progress	3	€455k
Amounts receivable within one year	40/41	€389k
Cash & bank	54/58	€166k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€3.43M
Equity	10/15	€2.38M
Contributions / capital	10/11	€3.50M
Accumulated profits (losses)	14	€-1.12M
Amounts payable	17/49	€1.05M
Amounts payable within one year	42/48	€1.05M
Trade debts payable within one year	44	€941k
Income statement
Gross operating margin	9900	€212k
Operating result	9901	€-711k
Financial charges	65	€2k
Result before taxes	9903	€-713k
Income taxes	67/77	€2k
Net result for the period	9904	€-715k
Result to be appropriated	9905	€-715k

Summary

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21014A0008/00Z010	Brussels	7,591 m²	1 · 6,964 m²	112.8 m · 22 fl.
25112C0124/00E000	Wallonia	2,426 m²	1 · 301 m²	6.5 m · 2 fl.